LEADER 06681nam 22006735 450 001 9910299865803321 005 20200703075836.0 010 $a3-319-90563-5 024 7 $a10.1007/978-3-319-90563-1 035 $a(CKB)3810000000358744 035 $a(MiAaPQ)EBC5446662 035 $a(DE-He213)978-3-319-90563-1 035 $a(PPN)229497942 035 $a(EXLCZ)993810000000358744 100 $a20180630d2018 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPublic Regulation of Tumor Banks $eEstablishment, Heritage Status, Development and Sharing of Human Biological Samples /$fedited by Xavier Bioy 205 $a1st ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (224 pages) 311 $a3-319-90562-7 327 $aPart I ? Tumor Banks or the Valorisation of a Complex Object: 1 Is Putting Cancer in Banks a Patrimony to be Developed? by Xavier Bioy -- 2 Biological Samples and Their Sampling Degrees by Thibaut Coussens-Barre -- 3 The Protection of Personal Data by Emilie Debaets -- 4 The Policies of Tumour Biobankers: Main Strategies and an Example of the Policies Adopted by the Nice Hospital Biobank, France by Paul Hofman -- 5 The Concept of Biological Samples Collection by Anne Brouchet and Sophie Peries -- 6 Does Tumour Bank Regulation Promote the Valorisation of Tumour Collections? by Anna Pigeon -- 7 Economic Modeling and Valorisation of Biobanks by Catherine Bobtcheff and Carole Haritchabalet -- 8 Socializing Tumours ? From the Conservation of Tumours in Banks to Their Ontological Variations by Fabien Milanovic -- Part II ? The Issues Related to Tumour Collections Valorisation: 9 The Valorisation of Tumour Collections: Reconciling the Interests of the Different Actors by Emmanuelle Rial-Sebbag.-10 The Development of Tumour Collections: The Interest of the European Union by Nathalie De Grove-Valdeyron -- Part III ? The Means for Tumour Collections Valorisation: 11 Academic Valorisation of Biobanks by Anne-Marie Duguet, Laurence Mabile and Anne Cambon-Thomsen -- 12 Marketing through the Use of Private Law Contracts by Laurent Izac -- 13 The Governance Framework of North American Biobanks: A Rapidly Evolving Policy Patchwork by Miriam Pinkesz and Yann Joly -- 14 Biobank Expertise and the Research Unit-biobank Relationship by Catherine Bobtcheff and Carole Haritchabalet -- 15 Extra-patrimoniality for the Patient by Sophie Paricard -- 16 The Moment of Patrimonialization by Marie-Xavière Catto -- 17 The Patrimonial Specificities of Public Persons by Benoît Schmaltz and Pierre Égéa -- 18 Biological Sample Collection in the Era of Genomic Medicine: A New Example of a Public Commons? by Christine Noiville and Florence Bellivier. 330 $aThe multidisciplinary book assesses the legal and economic uncertainties surrounding the collection, storage, provision and economic development of biological samples (tumors, tissues, cells) and associated personal data related to oncology. Public, partly public and private sector actors in the field of cancer care and research hold collections supported by significant public and social funding. Under certain conditions, particularly in the context of networking (sometimes promoted by public authorities), these collections can also represent major economic assets and scientific resources. However, this involves a number of issues and institutional constraints: legal: the will of the source person; non-pecuniary damage; freedom to establish collections; competence in deciding on their use; legal frameworks for their distribution; desire for return on investment for public institutions, notably in terms of industrial and intellectual property. economic: cost of establishing and running biological resource centres; destroying resources; emerging markets; profit sharing. public health policy choices: prioritisation of therapeutic measures over research (fundamental or clinical trials); conservation of resources; promotion of scientific (and not commercial) value of collections. The establishment, heritage recognition (?patrimonialisation?), development and sharing of these resources thus merit our calling into question present practices and their evolution, as well as the leverage available to public authorities (incentives, legislation, regulation) in a context where norms emerge from professional practice to become widely used in collaborative networks. Filling a gap in the current literature on law and economics, which pays little heed to these specific considerations, this book explores these considerations to bring to light the economic implications of ethical choices and governance issues in the health sector (structural organisation of local, national and European actors in oncology). It is intended for researchers in fields such as law, economics and biomedical sciences, as well as for public policymakers. 606 $aConflict of laws 606 $aConflict of laws 606 $aCancer$xResearch 606 $aMedical economics 606 $aLaw?Europe 606 $aMedical ethics 606 $aOncology 606 $aPrivate International Law, International & Foreign Law, Comparative Law $3https://scigraph.springernature.com/ontologies/product-market-codes/R14002 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aHealth Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W35000 606 $aEuropean Law$3https://scigraph.springernature.com/ontologies/product-market-codes/R20000 606 $aTheory of Medicine/Bioethics$3https://scigraph.springernature.com/ontologies/product-market-codes/H66000 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aConflict of laws. 615 0$aConflict of laws. 615 0$aCancer$xResearch. 615 0$aMedical economics. 615 0$aLaw?Europe. 615 0$aMedical ethics. 615 0$aOncology. 615 14$aPrivate International Law, International & Foreign Law, Comparative Law . 615 24$aCancer Research. 615 24$aHealth Economics. 615 24$aEuropean Law. 615 24$aTheory of Medicine/Bioethics. 615 24$aOncology. 676 $a362.1783 702 $aBioy$b Xavier$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910299865803321 996 $aPublic Regulation of Tumor Banks$92065558 997 $aUNINA LEADER 03472nam 2200661Ia 450 001 9910973241103321 005 20251116175925.0 010 $a1-134-86439-6 010 $a0-429-22961-5 010 $a0-585-46060-4 010 $a0-203-20408-5 010 $a1-280-32388-4 035 $a(CKB)1000000000252199 035 $a(EBL)165800 035 $a(OCoLC)560302624 035 $a(SSID)ssj0000210198 035 $a(PQKBManifestationID)11194358 035 $a(PQKBTitleCode)TC0000210198 035 $a(PQKBWorkID)10283293 035 $a(PQKB)10235711 035 $a(MiAaPQ)EBC165800 035 $a(Au-PeEL)EBL165800 035 $a(CaPaEBR)ebr10094958 035 $a(CaONFJC)MIL32388 035 $a(EXLCZ)991000000000252199 100 $a19930923d1994 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNew directions in economic methodology /$fedited by Roger E. Backhouse 205 $a1st ed. 210 $aLondon ;$aNew York $cRoutledge$d1994 215 $a1 online resource (409 p.) 225 1 $aEconomics as social theory 300 $aDescription based upon print version of record. 311 08$a0-415-09637-5 311 08$a0-415-09636-7 320 $aIncludes bibliographical references and index. 327 $aCover; New Directions in Economic Methodology; Copyright; Contents; Preface; 1. Introduction: New Directions in Economic Methodology; Part I. General Perspectives; 2. Ends and Means in the Methodology of Economics; 3. The Art of Economics by the Numbers; 4. What Are the Questions?; 5. The Sociology of Scientific Knowledge: Some Thoughts on the Possibilities; Part II. Falsificationism: for and Against; 6. Why I Am Not a Constructivist: Confessions of an Unrepentant Popperian; 7. Two Proposals for the Recovery of Economic Practice 327 $a8. Scientific Thinking Without Scientific Method: Two Views of PopperPart III. Philosophical Perspectives on Economics; 10. Kuhn, Lakatos and the Character of Economics; 11. What Is the Cognitive Status of Economic Theory?; 12. Reorienting the Assumptions Issue; 13. A Realist Theory for Economics; 14. Pragmatism, Pragmaticism and Economic Method; Part IV. Economics as Discourse; 15. How to Do a Rhetorical Analysis, and Why; 16. Metaphor and Economics; 17. The Economy as Text; Index 330 $aIn recent years there has been a flowering of work on economic methodology. However there is no longer any consensus about which direction this should take or, indeed, even what the role and content of economic methodology should be. This book reflects this diversity. Its contributors are responsible for the major developments in this field and together they give an account of all the major positions which currently prevail in economic methodology. These include attempts to rehabilitate the 'falsification' of Kuhn, Lakatos and Popper, sociology of knowledge approaches, different forms of reali 410 0$aEconomics as social theory. 606 $aEconomics$xMethodology 606 $aEconomics$xPhilosophy 615 0$aEconomics$xMethodology. 615 0$aEconomics$xPhilosophy. 676 $a330.01 676 $a330/.01 701 $aBackhouse$b Roger$0129631 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910973241103321 996 $aNew directions in economic methodology$94487459 997 $aUNINA